KANDLELIT-012: Phase 3 study of MK-1084 (a KRAS G12C inhibitor) plus cetuximab and mFOLFOX6 with or without bevacizumab for KRAS G12C-mutant colorectal cancer. This is an ASCO Meeting Abstract from ...
Special Notes Candidates Should Not Miss• Post Code ER15825 (10+2 Level) is recruiting only female candidates.• The results of some candidates have been withheld ...
SSC Phase-13 2025 Result: The Staff Selection Commission (SSC) has declared the results of the Phase-13 Selection Post 2025 CBT examination. The commission has declared the results for Matriculation, ...
SSC Phase 13 Answer Key 2026 has been released by the Staff Selection Commission for the Phase-XIII/2025/Selection Posts Examination on March 20, 2026 on its official ...